Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Anemia
•
Gastroenterology
•
GI bleed
What is your preferred approach in treating recurrent bleeding from GAVE?
What role does TIPS play when other approaches have been exhausted?
Answer from: at Community Practice
If repeated APC has not helped, I ask our advanced endoscopists to perform RFA. If it is a nodular GAVE, then banding is another option.
Comments
at Gastroenterology Associates Of Southern California
What's the evidence or opinion about APC or RFA wi...
14554
Sign in or Register to read more
Answer from: at Community Practice
I have had 3 patients over last 3 years that failed APC. In each case, RFA was well tolerated and was definite therapy.
Sign in or Register to read more
26030
26124
Related Questions
What is your approach to liver transplantation candidacy in those with decompensated cirrhosis who have been treated for a solid-organ malignancy, such as oral SCC?
Would you consider sotalol to be a suitable non-selective beta blocker for primary prevention of variceal bleeding in a patient who requires sotalol for treatment of arrhythmia in the setting of Fontan-associated liver disease and clinically significant portal hypertension?
How would you approach the treatment of an SLE patient with refractory mucocutaneous ulcerations and lichenoid skin eruption despite treatment with MMF, Aza, Benlysta, Saphnelo, Rituximab, and JAK inhibitors?
Do you accelerate your withdrawal time with the utilization of add-on devices to the colonoscope (such as EndoCuff) that enhance mucosal inspection and polyp detection?
Is there a role for use of dupilumab for hypereosinophilic GI disorders distal to the esophagus?
Is there a role for nitazoxanide for treatment of norovirus gastroenteritis in immunocompromised patients?
How do people approach non-HIV patients with hepatitis B, a negative Hepatitis B E antigen, normal LFTs and relatively low HBV DNA between 2000-20000?
What treatments have you found most effective for cholestatic pruritus?
When and how should we use biomarkers (i.e., CRP, stool calprotectin, mAb levels) to guide or optimize medical management of Crohn’s disease or ulcerative colitis?
Do you routinely recommend diagnostic endoscopy for patients with persistent enterococcus bacteremia despite receiving adequate antimicrobial therapy and no clear nidus?
What's the evidence or opinion about APC or RFA wi...